MENU
+Compare
CRNX
Stock ticker: NASDAQ
AS OF
Jul 10, 12:53 PM (EDT)
Price
$31.31
Change
-$1.02 (-3.15%)
Capitalization
3.03B

CRNX Crinetics Pharmaceuticals Forecast, Technical & Fundamental Analysis

Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors... Show more

CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CRNX with price predictions
Jul 09, 2025

CRNX's RSI Oscillator ascends from oversold territory

The RSI Indicator for CRNX moved out of oversold territory on July 02, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 22 similar instances when the indicator left oversold territory. In of the 22 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where CRNX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 09, 2025. You may want to consider a long position or call options on CRNX as a result. In of 104 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CRNX just turned positive on July 09, 2025. Looking at past instances where CRNX's MACD turned positive, the stock continued to rise in of 52 cases over the following month. The odds of a continued upward trend are .

CRNX moved above its 50-day moving average on July 09, 2025 date and that indicates a change from a downward trend to an upward trend.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where CRNX advanced for three days, in of 283 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The 10-day moving average for CRNX crossed bearishly below the 50-day moving average on June 24, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRNX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CRNX broke above its upper Bollinger Band on July 09, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for CRNX entered a downward trend on June 05, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CRNX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.415) is normal, around the industry mean (17.327). P/E Ratio (0.000) is within average values for comparable stocks, (59.374). CRNX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.418). Dividend Yield (0.000) settles around the average of (0.040) among similar stocks. CRNX's P/S Ratio (3333.333) is very high in comparison to the industry average of (272.335).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
CRNX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CRNX is expected to report earnings to rise 5.77% to -110 cents per share on August 08

Crinetics Pharmaceuticals CRNX Stock Earnings Reports
Q2'25
Est.
$-1.10
Q1'25
Missed
by $0.11
Q4'24
Est.
$-0.88
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.08
The last earnings report on May 08 showed earnings per share of -103 cents, missing the estimate of -93 cents. With 149.54K shares outstanding, the current market capitalization sits at 3.03B.
A.I. Advisor
published General Information

General Information

a developer of therapeutics for endocrine-related diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
6055 Lusk Boulevard
Phone
+1 858 450-6464
Employees
290
Web
https://www.crinetics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MOPCX19.390.17
+0.88%
NYLI WMC Small Companies Class C
PEQIX25.36N/A
N/A
Victory Pioneer Equity Income A
FSPTX38.95N/A
N/A
Fidelity Select Technology
GGFSX18.86N/A
N/A
Gabelli Global Financial Services A
CFMSX11.68N/A
N/A
Column Mid Cap Select

CRNX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CRNX has been loosely correlated with XNCR. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if CRNX jumps, then XNCR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRNX
1D Price
Change %
CRNX100%
+10.08%
XNCR - CRNX
61%
Loosely correlated
+12.82%
TRDA - CRNX
57%
Loosely correlated
+5.73%
KRYS - CRNX
55%
Loosely correlated
+3.88%
DYN - CRNX
55%
Loosely correlated
+5.84%
IDYA - CRNX
55%
Loosely correlated
+7.09%
More